13F-HR filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 99 holding rows worth $3,842,162,566.
- Accession
- 0001012975-23-000235
- Filer
- CIK 1224962
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 99 entries on the cover page, a total value of $3,842,162,566 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,842,162,566 with VALUE read as dollars as filed, 13F file number 028-10438. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VBI VACCINES INC | 91822J103 | COM NEW | 52,335,002 | $471,015,018 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 27,662,917 | $306,781,750 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 2,169,276 | $197,230,574 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 6,034,644 | $177,056,455 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 6,511,727 | $158,851,021 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 650,562 | $157,605,150 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 1,272,694 | $136,585,520 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 3,841,739 | $118,363,979 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 57,558,451 | $112,814,563 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 11,350,085 | $112,706,344 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 15,339,735 | $93,725,780 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 3,615,383 | $68,222,277 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,832,174 | $65,573,507 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 673,060 | $65,448,354 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 2,442,250 | $61,520,278 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 2,300,048 | $60,008,252 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,574,134 | $58,526,302 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 3,554,887 | $57,091,485 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,733,790 | $54,894,503 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 2,079,352 | $53,522,520 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 2,278,226 | $44,584,883 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,736,386 | $44,173,660 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,170,000 | $43,851,600 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 2,291,608 | $42,051,007 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 768,101 | $41,800,056 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 11,900,255 | $39,389,844 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 707,214 | $39,264,521 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 3,007,858 | $38,169,718 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 555,344 | $36,630,490 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,963,277 | $35,980,599 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 260,858 | $35,954,058 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 4,952,538 | $35,658,274 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 3,903,255 | $34,036,384 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 5,038,983 | $32,753,389 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,943,097 | $32,002,807 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 467,857 | $31,692,633 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,907,033 | $31,618,607 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 3,378,498 | $30,541,621 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 2,189,462 | $29,119,844 | dollars as filed | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 9,111,151 | $25,237,888 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,282,324 | $24,626,276 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,491,500 | $24,091,350 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 965,152 | $22,198,496 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 1,089,427 | $20,045,457 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,291,858 | $20,036,718 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 523,525 | $20,030,067 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,692,136 | $19,867,964 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 9,146,730 | $18,384,927 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 3,495,933 | $16,570,722 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,296,416 | $16,295,949 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,350,000 | $15,984,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 867,732 | $14,864,249 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 871,747 | $14,514,588 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 601,566 | $14,449,615 | dollars as filed | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 1,648,215 | $14,405,399 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 1,085,860 | $14,224,766 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 1,409,791 | $13,322,525 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 50,000 | $12,773,500 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 500,000 | $12,165,000 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 4,797,278 | $11,993,195 | dollars as filed | |
| CYTEK BIOSCIENCES INC | 23285D109 | COMMON STOCK | 1,289,534 | $11,850,817 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 237,646 | $11,518,702 | dollars as filed | |
| TACTILE SYSTEMS TECHNOLOGY I | 87357P100 | COMMON STOCK | 639,877 | $10,506,780 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 2,759,936 | $10,404,959 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 2,280,709 | $10,331,612 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 100,050 | $10,127,061 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 325,000 | $10,078,250 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 256,737 | $9,663,581 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 3,576,040 | $9,548,027 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 494,403 | $7,945,056 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $7,621,000 | dollars as filed | put |
| BELLEROPHON THERAPEUTICS INC | 078771300 | COM NEW | 930,000 | $7,337,700 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 406,024 | $6,711,577 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 724,777 | $5,993,906 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 590,000 | $5,404,400 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 4,298,212 | $4,985,926 | dollars as filed | |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 14,869,915 | $4,431,234 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 3,282,275 | $3,971,553 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 4,545,454 | $3,954,545 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 1,500,000 | $3,825,000 | dollars as filed | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 1,059,800 | $3,735,795 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 781,615 | $3,657,958 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 142,194 | $3,308,854 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 100,000 | $3,265,000 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 1,495,805 | $2,916,820 | dollars as filed | |
| BERKELEY LTS INC | 084310101 | COM | 2,506,442 | $2,907,473 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 1,752,745 | $2,558,131 | dollars as filed | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 6,726,496 | $2,287,009 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 90,748 | $2,040,923 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 130,000 | $1,465,100 | dollars as filed | |
| DARIOHEALTH CORP | 23725P209 | COM | 313,869 | $1,293,140 | dollars as filed | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 1,500,000 | $1,267,650 | dollars as filed | |
| ATHENEX INC | 04685N202 | COM NEW | 776,623 | $1,032,909 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 290,051 | $907,860 | dollars as filed | |
| PEAR THERAPEUTICS INC | 704723105 | COM | 900,548 | $229,639 | dollars as filed | |
| MOTUS GI HLDGS INC | 62014P405 | COM | 90,027 | $87,641 | dollars as filed | |
| EQRX INC | 26886C115 | *W EXP 12/17/202 | 250,000 | $43,125 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 60,000 | $28,908 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $16,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-23-000235 | this filing | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-23-000242 | base | 2023-05-16 | acceptance time not in the bulk data set |